Stay updated with breaking news from Karla Macdonald. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOSTON, May 16, 2024 -- Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage...
BOSTON, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal Escape Vehicle (EEV™)-therapeutics
- With a proven track record at Entrada and across his 30-year career in the healthcare sector, Mr. Dowden is well-positioned to help continue driving...
From sending handmade baby quilts to all-staff shoutouts, it’s good business to celebrate workers’ lives outside of the office.
– Initiated a Phase 1 clinical trial of ENTR-601-44 for the potential treatment of Duchenne muscular dystrophy, marking Entrada's transition to a clinical-stage company – – Expanded the Company's Duchenne franchise with